These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 10354412)
1. Simplified pepstatins: synthesis and evaluation of N-terminally modified analogues. Kratzel M; Schlichtner B; Kirchmayer R; Bernkop-Schnürch A J Med Chem; 1999 Jun; 42(11):2041-5. PubMed ID: 10354412 [TBL] [Abstract][Full Text] [Related]
2. Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues. Kratzel M; Hiessböck R; Bernkop-Schnürch A J Med Chem; 1998 Jun; 41(13):2339-44. PubMed ID: 9632367 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin. Bernkop-Schnürch A; Kirchmayer R; Kratzel M J Drug Target; 1999; 7(1):55-63. PubMed ID: 10614815 [TBL] [Abstract][Full Text] [Related]
4. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases. Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin. Rich DH; Sun ET; Ulm E J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029 [TBL] [Abstract][Full Text] [Related]
6. Valaminols, probably the most simplified peptide-analogs acting as pepsin inhibitors. Kratzel M; Bernkop-Schnürch A Peptides; 2000 Feb; 21(2):289-93. PubMed ID: 10764958 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the synthetic route to pepstatin analogues by SPPS using O-protected and O-unprotected statine as building blocks. Cadicamo CD; Asante V; Abu Ammar M; Borelli C; Korting HC; Koksch B J Pept Sci; 2009 Apr; 15(4):272-7. PubMed ID: 19189272 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249 [TBL] [Abstract][Full Text] [Related]
9. Impedance method for detecting HIV-1 protease and screening for its inhibitors using ferrocene-peptide conjugate/Au nanoparticle/single-walled carbon nanotube modified electrode. Mahmoud KA; Luong JH Anal Chem; 2008 Sep; 80(18):7056-62. PubMed ID: 18707132 [TBL] [Abstract][Full Text] [Related]
10. Pathogenic importance of pepsin in ischemia/reperfusion-induced gastric injury. Kotani T; Murashima Y; Kobata A; Amagase K; Takeuchi K Life Sci; 2007 May; 80(21):1984-92. PubMed ID: 17395212 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effect of structure in subsite P3 on inhibition of pepsin. Rich DH; Bernatowicz MS J Med Chem; 1982 Jul; 25(7):791-5. PubMed ID: 6809942 [TBL] [Abstract][Full Text] [Related]
12. A multifunctional protease inhibitor to regulate endolysosomal function. van Kasteren SI; Berlin I; Colbert JD; Keane D; Ovaa H; Watts C ACS Chem Biol; 2011 Nov; 6(11):1198-204. PubMed ID: 21910425 [TBL] [Abstract][Full Text] [Related]
13. Formulation development of epidermal growth factor. Lee J Pharmazie; 2002 Dec; 57(12):787-90. PubMed ID: 12561235 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery. Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay. Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and activity of phosphinic tripeptide inhibitors of cathepsin C. Mucha A; Paweł M; Hurek J; Kafarski P Bioorg Med Chem Lett; 2004 Jun; 14(12):3113-6. PubMed ID: 15149655 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin. Rich DH; Salituro FG J Med Chem; 1983 Jun; 26(6):904-10. PubMed ID: 6406670 [TBL] [Abstract][Full Text] [Related]
18. Pepstatin A induces extracellular acidification distinct from aspartic protease inhibition in microglial cell lines. Okada M; Irie S; Sawada M; Urae R; Urae A; Iwata N; Ozaki N; Akazawa K; Nakanishi H Glia; 2003 Aug; 43(2):167-74. PubMed ID: 12838508 [TBL] [Abstract][Full Text] [Related]
19. Parasite killing in Plasmodium vivax malaria by nitric oxide: implication of aspartic protease inhibition. Sharma A; Eapen A; Subbarao SK J Biochem; 2004 Sep; 136(3):329-34. PubMed ID: 15598889 [TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin. Smith PC; Santibañez JF; Morales JP; Martinez J J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]